Aging and endothelin: determinants of disease
- PMID: 25239727
- DOI: 10.1016/j.lfs.2014.09.009
Aging and endothelin: determinants of disease
Abstract
Since the beginning of the 20th century human life expectancy has doubled to more than 80 years, and growth and aging of the world population now represent major challenges for healthcare providers, political decision makers, and societies. Cellular senescence is associated with a general, pro-inflammatory state, which represents the common denominator between aging and chronic diseases and their progression. Approaches to interfere with these changes and to allow healthy aging involve modulation of the cellular activity of modifiable molecular mediators (MMMs), such as signaling molecules and growth factors. ET-1 - the biologically predominant member of the endothelin peptide family - is an endothelial cell-derived peptide with a wide variety of developmental and physiological functions, which include embryogenesis, nociception, and natriuresis. In addition, ET-1 is a cytokine-like, multifunctional peptide with pro-inflammatory, mitogenic, and vasoconstrictor properties. If produced in excess amounts ET-1 promotes disease - mainly via activation of its ETA receptor. Because of its multiple disease-promoting functions ET-1 represents an ideal _target MMM. Preclinical studies _targeting either activity or production of ET-1 - utilizing ERAs, ARBs, or ACEIs, respectively - have demonstrated that partial regression of aging-associated changes in vasculature and kidney is possible. In this article I will review the molecular regulation of ET-1 and its role in the physiology of vascular homeostasis, aging, and cellular senescence. The clinical implications of activators of ET-1 overproduction, modalities for delaying or reversing aging-related cellular changes, as well as interventions to promote healthy aging and early disease prevention - particularly physical activity - are discussed.
Keywords: ARB; Aged; Aging; Angiotenin converting enzyme inhibitor; Angiotensin; Angiotensin receptor blocker; Awareness; CKD; Cancer; Childhood; Chronic disease; Coronary artery disease; Diabetes; ERA; Education; Endothelin receptor antagonist; FSGS; Glomerulosclerosis; Health; Healthy aging; Heart failure; Hypertension; MMM; Modifiable molecular mediator; Obesity; Parents; Prevention; Renal disease; Schools; Senescence; Telomeres; Thomas Sydenham.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Endothelin: 30 Years From Discovery to Therapy.Hypertension. 2019 Dec;74(6):1232-1265. doi: 10.1161/HYPERTENSIONAHA.119.12105. Epub 2019 Nov 4. Hypertension. 2019. PMID: 31679425 Review.
-
Role of endothelin in cardiovascular disease.J Renin Angiotensin Aldosterone Syst. 2002 Mar;3(1):1-15. doi: 10.3317/jraas.2002.001. J Renin Angiotensin Aldosterone Syst. 2002. PMID: 11984741 Review.
-
Endothelin: role in hypertension.Biol Res. 1998;31(3):199-208. Biol Res. 1998. PMID: 9830507 Review.
-
The role of endothelins and their receptors in heart failure.Pharmacol Res. 2001 Feb;43(2):111-26. doi: 10.1006/phrs.2000.0758. Pharmacol Res. 2001. PMID: 11243712 Review.
-
Role of endothelin and endothelin receptor antagonists in renal disease.Eur J Clin Invest. 2006 Sep;36 Suppl 3:78-88. doi: 10.1111/j.1365-2362.2006.01689.x. Eur J Clin Invest. 2006. PMID: 16919017 Review.
Cited by
-
Relationship between endothelin and nitric oxide pathways in the onset and maintenance of hypertension in children and adolescents.Pediatr Nephrol. 2022 Mar;37(3):537-545. doi: 10.1007/s00467-021-05144-2. Epub 2021 Jun 3. Pediatr Nephrol. 2022. PMID: 34085102 Free PMC article. Review.
-
Altered endothelial ETB receptor expression in postmenopausal women.Am J Physiol Heart Circ Physiol. 2020 Jul 1;319(1):H242-H247. doi: 10.1152/ajpheart.00342.2020. Epub 2020 Jun 19. Am J Physiol Heart Circ Physiol. 2020. PMID: 32559137 Free PMC article.
-
Endothelin-1 induces cellular senescence and fibrosis in cultured myoblasts. A potential mechanism of aging-related sarcopenia.Aging (Albany NY). 2020 Jun 22;12(12):11200-11223. doi: 10.18632/aging.103450. Epub 2020 Jun 22. Aging (Albany NY). 2020. PMID: 32572011 Free PMC article.
-
The Relationship between Vascular Biomarkers (Serum Endocan and Endothelin-1), NT-proBNP, and Renal Function in Chronic Kidney Disease, IgA Nephropathy: A Cross-Sectional Study.Int J Mol Sci. 2024 Sep 30;25(19):10552. doi: 10.3390/ijms251910552. Int J Mol Sci. 2024. PMID: 39408883 Free PMC article.
-
Association of Big Endothelin-1 with Coronary Artery Calcification.PLoS One. 2015 Nov 13;10(11):e0142458. doi: 10.1371/journal.pone.0142458. eCollection 2015. PLoS One. 2015. PMID: 26565974 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical